UNITED THERAPEUTICS Corp — Proxy Solicitation & Information Statement 2021

Aug 19, 2021

DEFA14A 1 uthr3924131-defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant

CHECK THE APPROPRIATE BOX:
☐	Preliminary Proxy Statement
☐	Confidential, For Use of the Commission Only
(as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☑	Definitive Additional Materials
☐	Soliciting Material Under Rule
14a-12

United Therapeutics Corporation

(Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

| PAYMENT OF FILING FEE (CHECK THE APPROPRIATE

BOX):
☑	No fee
required.
☐	Fee computed on table below per Exchange Act Rules
14a-6(i)(1) and 0-11.
	1)
Title of each class of securities to which transaction
applies:
	2)
Aggregate number of securities to which transaction applies:
	3)
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
	4)
Proposed maximum aggregate value of transaction:
	5) Total fee paid:
☐	Fee paid previously with
preliminary materials:
☐	Check box if any part of the fee is
offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the form or schedule and the
date of its filing.
	1)
Amount previously paid:
	2)
Form, Schedule or Registration Statement No.:
	3)
Filing Party:
	4) Date
Filed:

UNITED THERAPEUTICS CORPORATION 1735 CONNECTICUT AVENUE, NW WASHINGTON, DC 20009
●
D58474-S29392

You invested in UNITED THERAPEUTICS CORPORATION and it’s time to vote! You have the right to vote on the proposal being presented at the Special Meeting. THIS IS AN IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIAL FOR THE SHAREHOLDER MEETING TO BE HELD ON SEPTEMBER 30, 2021.

Get informed before you vote View the Proxy Statement and the form of proxy online OR you can receive a free paper or email copy of the proxy material(s) by requesting prior to September 16, 2021. If you would like to request a copy of the proxy material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

●
Control #	●

Smartphone users Point your camera here and vote without entering a control number	●
●	Location: Virtual Special Meeting of Shareholders conducted exclusively via live audio webcast at: www.virtualshareholdermeeting.com/UTHR2021SM

• Please check the proxy materials for any special requirements for attending the virtual meeting.

V1

Vote at www.ProxyVote.com

THIS IS NOT A VOTABLE BALLOT

You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. Please follow the instructions on the reverse side to vote on this important matter.

Voting Items — 1.	Approval of an amendment to our Restated Certificate of Incorporation to become a public benefit corporation.	Board Recommends — ●	For

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.

D58475-S29392